Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov;6(6):535-40.
doi: 10.4168/aair.2014.6.6.535. Epub 2014 May 27.

Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis

Affiliations

Long-term Effects of Specific Allergen Immunotherapy Against House Dust Mites in Polysensitized Patients With Allergic Rhinitis

Sang Hoon Kim et al. Allergy Asthma Immunol Res. 2014 Nov.

Abstract

Purpose: Allergen-specific immunotherapy is the only currently available treatment to modify the natural history of allergic rhinitis (AR). If patients are polysensitized, it is difficult to identify the allergen causing the allergic symptoms. We evaluated the effectiveness of immunotherapy against house dust mites (HDMs) in AR patients polysensitized to both HDMs and seasonal allergens.

Methods: Thirty AR patients polysensitized to both HDMs and seasonal allergens (group A) and 30 patients sensitized to HDMs only (group B) were enrolled in this study. All subjects who received immunotherapy against HDMs for more than 2 years were evaluated by the multiple allergen simultaneous test (MAST) to determine the specific IgE level in luminescence units, total eosinophil counts in peripheral blood, serum total IgE, total nasal symptom scores, and the rhinoconjunctivitis quality of life questionnaire (RQLQ) before and after immunotherapy.

Results: There were no statistical differences in levels of total and specific IgE, or total eosinophil count between the two groups. The total nasal symptom scores, RQLQ and medication scores significantly decreased after immunotherapy in both groups, however no significant differences were noted between the two groups.

Conclusions: We determined that the primary causative allergen of AR in Seoul, Korea is perennial allergens, such as HDMs, rather than seasonal allergens. This study provides a reference for the selection of allergens to use in immunotherapy for polysensitized AR patients living in an urban environment.

Keywords: Immunotherapy; allergic rhinitis; house dust mite; polysensitization.

PubMed Disclaimer

Conflict of interest statement

There are no financial or other issues that might lead to conflict of interest.

Figures

Fig. 1
Fig. 1
Number of patients with severe allergic rhinitis symptoms during the season (*P<0.05).
Fig. 2
Fig. 2
Comparison of total nasal symptom scores pre- and post-treatment between Groups A and B (*P<0.05).
Fig. 3
Fig. 3
Comparison of RQLQ scores pre- and post-treatment between Groups A and B (*P<0.05).
Fig. 4
Fig. 4
Comparison of mean medication scores pre- and post-treatment between groups A and B (*P<0.05).

References

    1. Finegold I. Immunotherapy historical perspective. Ann Allergy Asthma Immunol. 2001;87:3–4. - PubMed
    1. Yu YI, Cho JS, Lee KH, Kim KH, Hong SM, Kim SW. Clinical statistical study on offending allergens of patients with allergic rhinitis: prevalence of multiple sensitization. Korean J Otolaryngol-Head Neck Surg. 2003;46:48–53.
    1. Jeong KY, Park JW, Hong CS. House dust mite allergy in Korea: the most important inhalant allergen in current and future. Allergy Asthma Immunol Res. 2012;4:313–325. - PMC - PubMed
    1. Hur GY, Kim TB, Han MY, Nahm DH, Park JW Allergen and Immunotherapy Work Group of the Korean Academy of Asthma, Allergy and Clinical Immunology (KAAACI) A survey of the prescription patterns of allergen immunotherapy in Korea. Allergy Asthma Immunol Res. 2013;5:277–282. - PMC - PubMed
    1. Park KH, Cho JS, Lee KH, Shin SY, Moon JH, Cha CI. Rhinoconjunctivitis quality of life questionnaire (RQLQ) as an evaluator of perennial allergic rhinitis patients-the first report. Korean J Otolaryngol-Head Neck Surg. 2002;45:254–262.